The FDA's Diversity Action Plan aims to enhance diversity in clinical trials. This panel discussion will provide an overview of the plan, its implications, and the feedback received. Experts will discuss strategies for implementing the plan's guidelines and improving trial diversity. Attendees will gain insights into promoting inclusive practices in their research. 

Learning Objectives: 

• Describe the FDA's Diversity Action Plan's key components and goals. 
• Analyze the implications of the Diversity Action Plan for clinical trial design and conduct. 
• Develop strategies to implement the plan's guidelines and enhance diversity in clinical trials. 
• Evaluate the feedback received on the Diversity Action Plan and its impact on trial practices. 
• Formulate action plans to promote inclusivity and ensure diverse participant representation in clinical research.